Background: (MRL)-lpr/lpr mice spontaneously develop autoimmune disease cha
racterized by arthritis and glumerulonephritis. Nitric oxide is postulated
to play a role in the disease pathogenesis, as mice treated with the nitric
oxide synthase inhibitor N-G-monomethyl-L-arginine (NMMA) show markedly re
duced manifestations of the disease. The purpose of this study was to exami
ne the role of peroxynitrite in disease development in MRL-lpr/lpr mice.
Materials and Methods: We examined kidney extracts from control and MRL-lpr
/lpr mice for nitrotyrosine by immunoblot with a rabbit polyclonal anti-nit
rotyrosine antibody. Catalase activity was determined spectrophotometricall
y or by activity staining of native polyacrylamide gels. In some experiment
s, we studied the ability of peroxynitrite and other agents to modify purif
ied catalase in vitro.
Results: Kidney extracts from diseased mice had elevated levels of nitrotyr
osine, and decreased levels of catalase activity and protein, relative to c
ontrol mice. MRL-lpr-lpr mice treated with NMMA in vivo had decreased level
s of nitrotyrosine, and demonstrated a partial restoration of both catalase
activity and protein levels. Treatment of catalase in vitro with peroxynit
rite or tetranitromethane at pH 8.0 resulted in protein nitration and a dec
rease in catalase activity. 1,3-morpholinosydnonimine (SIN-1), a peroxynitr
ite generator, also decreased the activity of catalase.
Conclusions: These observations suggest that peroxynitrite formation, with
an associated decrease in catalase activity and general decrease in antioxi
dant enzyme activity, may result in increased levels of hydrogen peroxide a
nd other oxidants that can contribute to the pathogenesis of disease in MRL
-lpr/lpr mice.